About ChemoMetec
ChemoMetec is a company based in Allerød (Denmark) founded in 1997.. The company has 174 employees as of June 30, 2025. ChemoMetec offers products and services including NucleoCounter® NC-3000™, XcytoMatic® 40, NucleoCounter® NC-250™, and XcytoMatic® 30. ChemoMetec operates in a competitive market with competitors including NanoCellect Biomedical, ThinkCyte, Silicon Biosystems, Cell Microsystems and Cytena, among others.
- Headquarter Allerød, Denmark
- Employees 174 as on 30 Jun, 2025
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Chemometec A/S
-
Annual Revenue
$78.05 M (USD)21.66as on Jun 30, 2025
-
Net Profit
$29.36 M (USD)36.78as on Jun 30, 2025
-
EBITDA
$39.01 M (USD)38.94as on Jun 30, 2025
-
Latest Funding Round
$395.61 K (USD), Grant
Oct 01, 2020
- Investors
-
Employee Count
174
as on Jun 30, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ChemoMetec
ChemoMetec is a publicly listed company on the OMXCOP with ticker symbol CHEMM in Denmark, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ChemoMetec
ChemoMetec offers a comprehensive portfolio of products and services, including NucleoCounter® NC-3000™, XcytoMatic® 40, NucleoCounter® NC-250™, and XcytoMatic® 30. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated instrument for precise cell counting in bioprocessing
Device for cell density analysis in life sciences research
Compact tool for automated cell analysis in various applications
Instrument for reliable cell density measurements in biotech
Unlock access to complete
Unlock access to complete
Funding Insights of ChemoMetec
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $395,612
-
First Round
First Round
(01 Oct 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Grant - ChemoMetec | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ChemoMetec
ChemoMetec has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ChemoMetec
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ChemoMetec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chemometec Comparisons
Competitors of ChemoMetec
ChemoMetec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, ThinkCyte, Silicon Biosystems, Cell Microsystems and Cytena, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops flow cytometry and cell sorting technology
|
|
| domain | founded_year | HQ Location |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| domain | founded_year | HQ Location |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a technology to isolate and recover single cells for molecular analysis
|
|
| domain | founded_year | HQ Location |
Single cells are isolated using the cy-Clone device technology.
|
|
| domain | founded_year | HQ Location |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chemometec
Frequently Asked Questions about ChemoMetec
When was ChemoMetec founded?
ChemoMetec was founded in 1997 and raised its 1st funding round 23 years after it was founded.
Where is ChemoMetec located?
ChemoMetec is headquartered in Allerød, Denmark.
How many employees does ChemoMetec have?
As of Jun 30, 2025, the latest employee count at ChemoMetec is 174.
What is the annual revenue of ChemoMetec?
Annual revenue of ChemoMetec is $78.05M as on Jun 30, 2025.
What does ChemoMetec do?
ChemoMetec develops automated cell counters and analyzers, as well as associated consumables. Its flagship product range NucleoCounter has four different cytometers that use automated image analysis and fluorescent markers for cell counting, a sperm counter, a yeast cell counter, and two different somatic cell counters. Assays that can be performed on the cytometers include cell death and apoptosis assays, cell cycle assays, DNA fragmentation assays, transfection efficiency assays, mitochondrial potential assays, cell viability assays, vitality assays, mammalian and aggregated cell assays, whole blood assays, and the companys proprietary FlexiCyte assay for mammalian cell analysis.
Who are the top competitors of ChemoMetec?
ChemoMetec's top competitors include NanoCellect Biomedical, ThinkCyte and Silicon Biosystems.
What products or services does ChemoMetec offer?
ChemoMetec offers NucleoCounter® NC-3000™, XcytoMatic® 40, NucleoCounter® NC-250™, and XcytoMatic® 30.
Is ChemoMetec publicly traded?
Yes, ChemoMetec is publicly traded on OMXCOP under the ticker symbol CHEMM.
Who are ChemoMetec's investors?
ChemoMetec has 1 investor. Key investors include European Union.
What is ChemoMetec's ticker symbol?
The ticker symbol of ChemoMetec is CHEMM on OMXCOP.